According to a new report by Univdatos Market Insights, the Botulinum Toxin Market is expected to reach USD 19 Billion in 2032 by growing at a CAGR of ~8.5%. Botulinum toxin, commonly known by its commercial names such as Botox, Dysport, and Xeomin, has long been a staple in aesthetic medicine for its ability to reduce the appearance of fine lines and wrinkles. Botulinum Toxin is...